Skip to main content
Could This New Therapy Stop Alzheimer’s in Its Tracks?
Checking your sign-in status…
Reversing Alzheimer’s Summit 2.0

Could This New Therapy Stop Alzheimer’s in Its Tracks?

James Maskell
James Maskell

Founder, Functional Forum

Rajka Milanovic Galbraith
Rajka Milanovic Galbraith

Founder, Simply Health Institute

  • Discover how TB 006, a promising new monoclonal antibody, may dramatically slow Alzheimer’s progression by reducing brain inflammation.
  • Learn why gut health, detoxification, and inflammation control are critical to preventing and reversing cognitive decline.
  • Uncover how peptides and cutting-edge functional medicine strategies can restore brain function and improve quality of life.

Comments